DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs.

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

DAIC

NOVEMBER 8, 2024

tim.hodson Fri, 11/08/2024 - 13:23 Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter that integrates two critical PAD treatments into a single device.

Innovation 52

Innovation Peripheral Arterial Disease Technology Ultrasound 52

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. The DynamX bioadaptor has a novel design and mechanism of action designed to return the diseased vessel to a more normal condition, through three distinct phases.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

JANUARY 9, 2024

The roundtable provided a unique opportunity to identify knowledge gaps and discuss how IVUS can enhance our understanding and treatment of peripheral arterial and deep venous pathology." IVUS is a minimally invasive imaging technique that allows physicians to visualize the inside of blood vessels in real-time.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Ultrasound Angioplasty Interventional Cardiology 105

The British Journal of Cardiology

AUGUST 1, 2024

Large-scale observational data have demonstrated a robust, independent association of elevated lipoprotein(a) (Lp[a]) levels with atherosclerotic cardiovascular disease (CVD), stroke, and peripheral artery disease.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Myocardial Infarction Plaque Cardiovascular Disease 40

DAIC

DECEMBER 16, 2024

tim.hodson Mon, 12/16/2024 - 12:19 Dec.13, For PAD, the clot-sensing technology is being developed to instantly identify fresh clot and differentiate it from organized clot thrombus poor in RBCs as well as plaque, calcium and other tissue in real-time to inform individualized PAD treatment. Please visit Sensome for more information.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Technology Plaque Stroke 52

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105